Literature DB >> 11932441

Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria.

Caroline Westwater1, David A Schofield1, Michael G Schmidt1, James S Norris1, Joseph W Dolan1.   

Abstract

The inability to transform many clinically important Gram-negative bacteria has hampered genetic studies addressing the mechanism of bacterial pathogenesis. This report describes the development and construction of a delivery system utilizing the broad-host-range transducing bacteriophage P1. The phagemids used in this system contain a P1 pac initiation site to package the vector, a P1 lytic replicon to generate concatemeric DNA, a broad-host-range origin of replication and an antibiotic-resistance determinant to select bacterial clones containing the recircularized phagemid. Phagemid DNA was successfully introduced by infection and stably maintained in members of the families Enterobacteriaceae (Escherichia coli, Shigella flexneri, Shigella dysenteriae, Klebsiella pneumoniae and Citrobacter freundii) and Pseudomonadaceae (Pseudomonas aeruginosa). In addition to laboratory strains, these virions were used successfully to deliver phagemids to a number of strains isolated from patients. This ability to deliver genetic information to wild-type strains raises the potential for use in antimicrobial therapies and DNA vaccine development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932441     DOI: 10.1099/00221287-148-4-943

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Scalable plasmid transfer using engineered P1-based phagemids.

Authors:  Joshua T Kittleson; Will DeLoache; Hsiao-Ying Cheng; J Christopher Anderson
Journal:  ACS Synth Biol       Date:  2012-08-30       Impact factor: 5.110

Review 2.  Current and future prospects for CRISPR-based tools in bacteria.

Authors:  Michelle L Luo; Ryan T Leenay; Chase L Beisel
Journal:  Biotechnol Bioeng       Date:  2015-10-27       Impact factor: 4.530

3.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

4.  Specific gene repression by CRISPRi system transferred through bacterial conjugation.

Authors:  Weiyue Ji; Derrick Lee; Eric Wong; Priyanka Dadlani; David Dinh; Verna Huang; Kendall Kearns; Sherry Teng; Susan Chen; John Haliburton; Graham Heimberg; Benjamin Heineike; Anusuya Ramasubramanian; Thomas Stevens; Kara J Helmke; Veronica Zepeda; Lei S Qi; Wendell A Lim
Journal:  ACS Synth Biol       Date:  2014-12-06       Impact factor: 5.110

5.  Inducible directed evolution of complex phenotypes in bacteria.

Authors:  Ibrahim S Al'Abri; Daniel J Haller; Zidan Li; Nathan Crook
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

6.  Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems.

Authors:  Ahmed A Gomaa; Heidi E Klumpe; Michelle L Luo; Kurt Selle; Rodolphe Barrangou; Chase L Beisel
Journal:  MBio       Date:  2014-01-28       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.